This article has expired, however you can still
download the PDF
Kite Pharma, Inc. (Nasdaq:KITE) today announced the closing of its
previously announced underwritten public offering of 4,750,000 shares of
its common stock at a price to the public of $75.00 per share, as well
as the exercise i...